New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
WEL9 ETF · Amundi S&P World Health Care Screened UCITS ETF
The WEL9 Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: S&P World Health Care Weighted & Screened Index. The WEL9 ETF provides physical exposure, so by buying it you actually own parts of all the 86 underlying holdings. The dividend policy is capitalization.
Share class
Acc
EUR
Real-time data unavailable for WEL9
LIVE
CLOSED
This fund is part ofWorld Health Care1M perf.-5.33%
Last price
N/A
1M perf.
-2.55%
1M flows
+€91M
AuM
€328M
E/R
0.18%
Rating
Not rated
ESG Consensus®
WEL9
N/A
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
WEL9
€10.94
-1.89%
World Health Care
-2.29%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -2.55%  | -1.89%  | -3.87%  | +14.07% | N/A | -4.89% | -3.29% | -3.29%  | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/12/2026
€10.94
1D NAV change
-1.44%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
86
Inception date
9/20/2022
Jurisdiction
Ireland
Distribution
Netherlands
Sweden
Norway
Hungary
Finland
Legal structure
Irish Collective Asset-management Vehicle
Base currency
EUR
Classification
Product type
Benchmark
S&P World Health Care Weighted & Screened Index
Asset class
Factors
N/A
Share class info
EUR capitalizing
Total AuM of fund
€455M
Decimalisation of shares
No
Investment strategy
Amundi S&P World Health Care Screened UCITS ETF seeks to replicate, as closely as possible, whether the trend is rising or falling, the performance of the S&P World Health Care Weighted & Screened Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. For further information, please refer to the fund prospectus or KID.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
WELZ
1M perf.
-2.55%
E/R
0.18%
WDHE
1M perf.
-5.46%
E/R
0.18%
IXJ
1M perf.
-5.34%
E/R
0.4%
IXJ
1M perf.
-4.74%
E/R
0.47%
XHC
1M perf.
-4.64%
E/R
0.66%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -1.89% | -3.87% | +14.07% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
67.72%
Switzerland
10.11%
United Kingdom
5.99%
Japan
3.98%
Denmark
3.21%
France
2.71%
Ireland
2.60%
Australia
1.16%
Other
2.53%
Sectors
Health Care
94.89%
Consumer Discretionary
1.18%
Unavailable
3.93%
Diversification
Total weight of top 15 holdings out of 86
Top 15 holdings
Data as of January 31, 2026
LILLY
ABBVIE
ROCHE
UNITEDHEALTH GRP
ASTRAZENECA
MERCK & CO INC
NOVARTIS
THERMO FISHER SCIENTIFIC
Create a free account to view top holdings
AMGEN-T
DK0062498333
INTUITIVE SURGICAL
GILEAD SCIENCES
ABBOTT LABS
DANAHER
BOSTON SCIENTIFIC
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
Yes
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about WEL9 ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
WEL9’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
95.68% of holdings have positive scoring
4.32% of holdings have negative scoring
6.20%
72.86%
16.62%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Amundi
Amundi ID Card
Number of funds
632
Total AuM
€362.42B
Expense ratio range
0.03% - 0.85%
Average expense ratio
0.2336%
Top 5 funds by Amundi
| AuM | ||
|---|---|---|
MEUDN | Amundi Core Stoxx Europe 600 UCITS ETF | €16.75B |
SP5L | Amundi Core S&P 500 Swap UCITS ETF | €13.04B |
GOLD | AMUNDI PHYSICAL GOLD ETC | €12.24B |
MWRD | Amundi Core MSCI World UCITS ETF | €12.19B |
WLD | Amundi MSCI World Swap II UCITS ETF | €7.7B |
Frequently asked questions about WEL9
What does Amundi S&P World Health Care Screened UCITS ETF, WEL9, invest in?
WEL9 is a Passive ETF. This ETF provides exposure to Other Large and Mid-Cap Developed markets Health Care Equities.
Which benchmark or index does WEL9 replicate?
WEL9 tracks the S&P World Health Care Weighted & Screened Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of WEL9?
WEL9 carries a total expense ratio (TER) of 0.18%, indicating the annual cost for holding the fund.
When was WEL9 launched?
WEL9 was introduced to the market on September 20, 2022. It trades on Netherlands, among other exchanges
Who is the ETF issuer of WEL9?
Amundi S&P World Health Care Screened UCITS ETF, WEL9, is provided by Amundi. Learn more about Amundi here.
Does WEL9 have multiple share classes?
Yes, WEL9 is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .
What is the current assets under management (AUM) of WEL9?
WEL9 oversees €328M in assets as of March 12, 2026.
How has WEL9 performed lately?
Based on data from March 12, 2026, WEL9 returned -2.55% over the past month, -1.89% over the last three months and -3.29% year-to-date.
What are the latest inflows or outflows for WEL9?
As of March 12, 2026, WEL9 recorded net flows of +€91M over the last month and +€83M year-to-date.
Does WEL9 distribute dividends?
WEL9 follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of WEL9?
As of January 31, 2026, WEL9 has significant geographic allocations in USA, Switzerland and United Kingdom.
In which sector or theme does WEL9 invest in?
As of January 31, 2026, WEL9 focuses largely on Health Care and Consumer Discretionary.
How many securities does WEL9 hold and how diversified is it?
As of January 31, 2026, WEL9 holds 86 positions in its portfolio, with 61.57% of assets concentrated in its top 15 holdings.
What are the main positions in WEL9?
As of January 31, 2026, WEL9 top three holdings include LILLY, ABBVIE and ROCHE.
What is the base currency of WEL9?
The base currency of WEL9 is EUR.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
